Overview Covers in-demand tech skills, including AI, cloud computing, cybersecurity, and full-stack development for ...

Ocugen has reported preliminary phase 2 data on its eye disease gene therapy, providing more evidence that the candidate may ...

By the numbers, everything is going great for creators. So why are so many of them scared it’s all about to fall apart?

AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, recently announced that the United States Food and Drug Administration (FDA) has ...

After greenlighting 56 novel therapeutics in 2025, four notable applications continue to await the agency’s action after ...

Precigen, Inc. ( PGEN) 44th Annual J.P. Morgan Healthcare Conference January 15, 2026 10:30 AM EST ...

Apple Creator Studio is taking on Adobe's dominant Creative Cloud by offering a selection of apps to create content, paid ...

Apple is entering the subscription model with an all-new suite of creative apps. Apple Creator Studio includes Final Cut Pro, ...

LX2020 generally well tolerated across ten participants with no clinically significant complement activation LX2020 transduction, transcription, ...

South Asia’s strategic location, fragmented politics, and regional rivalries make it an ideal testing ground for the GSI’s ...

SOPHiA GENETICS , a global leader in AI-driven precision medicine, today provided preliminary unaudited financial results for the fourth quarter and full year 2025, initiated its financial outlook for ...

CrossWorlds hoists itself up with some of the cleanest, most robust kart racing I've seen on PC, tracks that leave a ton of ...